This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
ASH 2020 is OPEN (virtually) and CLL Society is reporting!
Conference Coverage 2020
ASH 2020 Pre-ASH Satellite Symposia
Dr. Brian Koffman attended 2 amazing pre-ASH symposia:
- Mapping the New Era in CLL Management: Precision Medicine and Patient Perspectives in Treatment-Naïve and Relapsed Disease featuring, among others, CLL expert Dr. John Gribben and CLL Society’s Director of Support Groups 20-year CLL survivor Terry Evans in a case-based learning format. This event was co-sponsored by CLL Society & PeerView Institute. (See link to the archived version of this event below under “In case you missed it.”
- Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes. This session, featuring three members of the CLLS Medical Advisory Board: Drs. Ian Flinn, Susan O’Brien and John Pagel, was full of great information and linked to resources that Clinical Care Options (CCO) and CLL Society co-developed to educate community hematologists. Dr. Koffman’s video is full of teasers, hinting at soon-to-be presented data. Don’t miss his long and lively riff on “We know this!” and “We know that!” about CLL. Now, let’s try to keep up with him!
ASH 2020 Day One Update is here! ASH officially started early Saturday morning, Dec. 5 with a fireside chat between ASH president, Dr. Stephanie Lee and Dr. Anthony Fauci, the director of the NIH’s NIAID, who shared his recommendation that immunosuppressed patients with blood cancers, like us, get the vaccine, because some immunity is better than none. For Dr. Koffman’s daily video, he chose to focus on the four oral presentations devoted to the latest clinical trial news about limited duration therapies, all of which included venetoclax: The CAPTIVATE, CLARITY, MURANO and CLL14 trials. Watch here.
ASH 2020 Day Two Update CLL Biology
Dr. Koffman’s Day 2 Updates are thick with science as he acquaints us with persistent skinny lymph nodes, combinations & high-risk disease, and more. Watch here.
Conference Coverage 2019
The library of video interviews is still flowing strong from our ASH 2019 efforts, and below we hope to enrich your understanding about the hopes pinned to off-the-shelf bi-specific antibodies as described by Drs. Patel and Wiestner.
Dr. Brian Koffman interviewed Dr. Krish Patel at ASH 2019, about how our native immune system is excellent at controlling cancer when it is working normally. In CLL, the immune system has become dysregulated and does a poor job controlling cancer. Could modifying the immune system with off-the-shelf bi-specific antibodies repair this problem? Watch Dr. Patel’s interview here.
Also during ASH 2019, Dr. Koffman interviewed Dr. Adrian Wiestner, who discussed bi-specific antibodies to improve the immune system in CLL patients. There is reason to believe that when used in combination with a BTK inhibitor such as ibrutinib, they would have increased effectiveness, as ibrutinib improves T cell function. Watch Dr. Wiestner’s interview here.
Do I need a Pulse Oximeter?
Along with a thermometer, a pulse oximeter is perhaps the most useful home diagnostic medical device needed during this COVID-19 pandemic. What is a Pulse Oximeter? A pulse oximeter is a small non-invasive electronic oxygen saturation measuring device that can be gently clipped onto a body part, usually a fingertip, but occasionally elsewhere such as a toe or earlobe, to measure blood oxygen levels. What does it measure? Simply put, the pulse oximeter measures if there is enough oxygen in your blood. What is a normal reading and when should I be concerned? Low oxygen is called hypoxia and needs urgent medical attention! Should I have one to help me during the pandemic? Dr. Brian Koffman tells all and shows you a photo here.
In case you missed it: Here is the Replay of Terry Evan’s event.
A webinar which took place Dec. 4 which featured 20-year CLL survivor Terry Evans, Director of CLL Society Support Groups, and CLL Expert Dr. John Gribben, and panelists Drs. Ryan Jacobs, Allesandra Tedeschi and Philip Thompson in a CLL Society/ Peerivew joint-sponsored pre-ASH 2020 event! An expert panel presented practice-changing evidence for the treatment of CLL with novel therapeutics and explored real-world patient case scenarios. Also featured were perspectives on the patient’s experience of CLL therapy. See our replay here.
Celebrating 10 Years of ASH!
We are celebrating 10 Years of covering ASH (and all the other major hematology conferences) to bring you the most important, breaking CLL research news in patient-friendly terms. Support the ongoing work of the CLL Society. Please donate today. Thank you!
Please support the CLL Society, the only CLL-specific, physician-curated public charity dedicated to meeting the unmet needs of CLL patients and their caregivers which holds the GuideStar Platinum Seal of Transparency.
Thank you and stay safe!
We are all in this together.
Co-Founder & Communications Director
CLL Society Support Group Meetings Coming Up!
CLL Society Support Group meetings have moved to a virtual platform for most locations due to the threat of coronavirus. Support group members will receive an invitation to register for the meeting from the support group facilitator. If you are new to the group, please contact the RSVP email for the Support Group in your region. Once it is safe again, we will resume in-person meetings.
Visit the individual event listings on our website for the most up-to-date information on all CLL Society Support Group meetings.